Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

Affiliations

• ¹ Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan. motoy@kuhp.kyoto-u.ac.jp.
• ² Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan. motoy@kuhp.kyoto-u.ac.jp.
• ³ Department of Urology, Graduate School of Medicine, Juntendo University, Bunkyo City, Tokyo, Japan.
• ⁴ Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
• ⁵ Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
• ⁶ Department of Academic Education, I and H Co., Ltd, Ashiya, Japan.
• ⁷ Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, Bunkyo City, Tokyo, Japan.
• ⁸ Department of Thoracic Oncology, Aichi Cancer Center, Nagoya, Japan.
• ⁹ Department of Blood Purification, Tokyo Women's Medical University, Shinjuku City, Tokyo, Japan.
• ¹⁰ Department of Respiratory Medicine, Anjo Kosei Hospital, Anjo, Japan.
• ¹¹ Department of Nephrology, Tokyo Women's Medical University, Shinjuku City, Tokyo, Japan.
• ¹² Department of Pediatrics, Shiga University of Medical Science, Otsu, Shiga, Japan.
• ¹³ Department of Renal and Urologic Surgery, International University of Health and Welfare Narita Hospital, Chiba, Japan.
• ¹⁴ Department of Pediatrics, Kitasato University School of Medicine, Minato, Kanagawa, Japan.
• ¹⁵ Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
• ¹⁶ Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan.
• ¹⁷ Department of Obstetrics and Gynecology, Keio University School of Medicine, Minato, Tokyo, Japan.
• ¹⁸ Department of Pharmacy, Seichokai Fuchu Hospital, Izumi, Japan.
• ¹⁹ Departments of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
• ²⁰ Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
• ²¹ Department of Pharmacy, Wakayama Medical University Hospital, Wakayama, Japan.
• ²² Hyogo Cancer Center, Akashi, Hyogo, Japan.
• ²³ Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
• ²⁴ Department of Hematology, Chiba University Hospital, Chiba, Japan.
• ²⁵ Division of Nephrology and Hypertension, Department of Internal Medicine, Saint Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
• ²⁶ Division of Medical Oncology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
• ²⁷ Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.
• ²⁸ Department of Nursing, Seirei Sakura Citizen Hospital, Chiba, Japan.
• ²⁹ Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Hyogo, Japan.
• ³⁰ Department of Pharmacy, The University of Tokyo Hospital, Bunkyo City, Tokyo, Japan.
• ³¹ Department of Pharmacy, Kobe University Hospital, Kobe, Japan.
• ³² Department of Nephrology, Internal Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
• ³³ Department of Urology, Keio University School of Medicine, Minato, Tokyo, Japan.
• ³⁴ Department of Nephrology, Saitama Medical University, Saitama, Japan.
• ³⁵ Division of Nephrology and Endocrinology, The University of Tokyo, Bunkyo City, Tokyo, Japan.
• ³⁶ Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan.